FDA Moves to Ban Trans Fats
U.S. food safety officials are taking steps to prohibit the use of trans fats in foods, a move they say could prevent 7,000 deaths and 20,000 heart attacks each year.
U.S. food safety officials are taking steps to prohibit the use of trans fats in foods, a move they say could prevent 7,000 deaths and 20,000 heart attacks each year.
Also known as partially hydrogenated oils, trans fats are no longer “generally recognized as safe,” the Food and Drug Administration said. The office will open a 60-day consultation period on the plan.
“While consumption of potentially harmful artificial trans fat has declined over the last two decades in the United States, current intake remains a significant public health concern,” FDA Commissioner Margaret Hamburg said in a statement Thursday. “The FDA’s action today is an important step toward protecting more Americans from the potential dangers of trans fat.”
— Posted by Alexander Reed Kelly.
Your support matters…BBC:
If the agency’s plan [is] successful, the heart-clogging oils would be considered food additives and could not be used in food unless officially approved.
The ruling does not affect foods with naturally occurring trans fats, which are present in small amounts in certain meat and dairy products.
Artificial trans fats are used both in processed food and in restaurants as a way to improve the shelf life or flavour of foods. The fats are created when hydrogen is added to vegetable oil, making it a solid.
Independent journalism is under threat and overshadowed by heavily funded mainstream media.
You can help level the playing field. Become a member.
Your tax-deductible contribution keeps us digging beneath the headlines to give you thought-provoking, investigative reporting and analysis that unearths what's really happening- without compromise.
Give today to support our courageous, independent journalists.
Editorial Cartoons
Women
A pharmacist and public health expert explain this new era in contraception.
Technology
Elon Musk's company has been hyping up human trials for years but only after a myriad of scandals around animal testing.
TD Original
In previously unreported statements made at the 2017 International Drug Policy Reform Conference, Rick Doblin, executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), discussed rumors of secret Pentagon studies with MDMA, as well as the reasons for hesitancy on the part of some government agencies to fund MAPS’ research.
The FDA’s strict guidance on test confirmations is one of several obstacles that has slowed the federal government’s response to COVID-19. The FDA could change its rules to speed things up, but hasn’t.
The agency's OK, four months after it rejected the drug over safety concerns, may stoke questions about standards for clearing medications.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.